Biliary Anomalies in Patients With HNF1B Diabetes

Show simple item record Kettunen, Jarno L. T. Parviainen, Helka Miettinen, Päivi J. Färkkilä, Martti Tamminen, Marjo Salonen, Pia Lantto, Eila Tuomi, Tiinamaija 2017-07-10T11:12:00Z 2017-07-10T11:12:00Z 2017-06
dc.identifier.citation Kettunen , J L T , Parviainen , H , Miettinen , P J , Färkkilä , M , Tamminen , M , Salonen , P , Lantto , E & Tuomi , T 2017 , ' Biliary Anomalies in Patients With HNF1B Diabetes ' , Journal of Clinical Endocrinology and Metabolism , vol. 102 , no. 6 , pp. 2075-2082 .
dc.identifier.other PURE: 86764026
dc.identifier.other PURE UUID: df40d2e5-7780-49cc-b998-7266bb8f0891
dc.identifier.other WOS: 000403139100034
dc.identifier.other Scopus: 85020421154
dc.identifier.other ORCID: /0000-0002-0250-8559/work/39204256
dc.identifier.other ORCID: /0000-0002-5184-9616/work/39204353
dc.identifier.other ORCID: /0000-0002-8306-6202/work/52694940
dc.identifier.other ORCID: /0000-0002-9995-698X/work/64325504
dc.description.abstract Context: The clinical spectrum of organogenetic anomalies associated with HNF1B mutations is heterogeneous. Besides cystic kidney disease, diabetes, and various other manifestations, odd cases of mainly neonatal and posttransplantation cholestasis have been described. The biliary phenotype is incompletely defined. Objective: To systematically characterize HNF1B-related anomalies in the bile ducts by imaging with magnetic resonance imaging (MRI) or magnetic resonance cholangiopancreatography (MRCP). Setting and Patients: Fourteen patients with HNF1B mutations in the catchment area of the Helsinki University Hospital were evaluated with upper abdominal MRI and MRCP. Blood samples and clinical history provided supplemental data on the individual phenotype. Main Outcome Measure(s): Structural anomalies in the biliary system, medical history of cholestasis, other findings in abdominal organs, diabetes and antihyperglycemic treatment, hypomagnesemia, and hyperuricemia. Results: Structural anomalies of the bile ducts were found in seven of 14 patients (50%). Six patients had choledochal cysts, which are generally considered premalignant. Conclusions: Structural anomalies of the biliary system were common in HNF1B mutation carriers. The malignant potential of HNF1B-associated choledochal cysts warrants further studies. en
dc.format.extent 8
dc.language.iso eng
dc.relation.ispartof Journal of Clinical Endocrinology and Metabolism
dc.rights unspecified
dc.rights.uri info:eu-repo/semantics/openAccess
dc.subject MUTATIONS
dc.subject GENE
dc.subject YOUNG
dc.subject MANAGEMENT
dc.subject LIVER
dc.subject 3121 General medicine, internal medicine and other clinical medicine
dc.title Biliary Anomalies in Patients With HNF1B Diabetes en
dc.type Article
dc.contributor.organization Research Programs Unit
dc.contributor.organization Diabetes and Obesity Research Program
dc.contributor.organization Endokrinologian yksikkö
dc.contributor.organization Department of Medicine
dc.contributor.organization Clinicum
dc.contributor.organization HUS Abdominal Center
dc.contributor.organization Department of Diagnostics and Therapeutics
dc.contributor.organization HUS Medical Imaging Center
dc.contributor.organization HUS Children and Adolescents
dc.contributor.organization Children's Hospital
dc.contributor.organization Lastentautien yksikkö
dc.contributor.organization Gastroenterologian yksikkö
dc.contributor.organization Institute for Molecular Medicine Finland
dc.contributor.organization Tiinamaija Tuomi Research Group
dc.description.reviewstatus Peer reviewed
dc.relation.issn 0021-972X
dc.rights.accesslevel openAccess
dc.type.version publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
Biliary_Anomalies.pdf 901.4Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record